ArticleAnti-cancer drugs2010

Safety evaluation and pharmacokinetics of a novel human tumor necrosis factor-alpha exhibited a higher antitumor activity and a lower systemic toxicity.

Meng Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.